• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advancing proteomics and machine learning in the clinic: an editorial on "".

作者信息

McGinnis Courtney D, Graham Brenton I M, Harris Peter S, Fritz Kristofer S

机构信息

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

Hepatobiliary Surg Nutr. 2022 Oct;11(5):762-765. doi: 10.21037/hbsn-22-390.

DOI:10.21037/hbsn-22-390
PMID:36268253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9577981/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fafa/9577981/a74b6516a2fb/hbsn-11-05-762-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fafa/9577981/a74b6516a2fb/hbsn-11-05-762-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fafa/9577981/a74b6516a2fb/hbsn-11-05-762-f1.jpg

相似文献

1
Advancing proteomics and machine learning in the clinic: an editorial on "".临床蛋白质组学与机器学习的进展：关于《》的一篇社论
Hepatobiliary Surg Nutr. 2022 Oct;11(5):762-765. doi: 10.21037/hbsn-22-390.
2
Proteomics and machine-learning models for alcohol-related liver disease biomarkers.用于酒精性肝病生物标志物的蛋白质组学和机器学习模型
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):488. doi: 10.1038/s41575-022-00655-1.
3
[Research progress of feature selection and machine learning methods for mass spectrometry-based protein biomarker discovery].基于质谱的蛋白质生物标志物发现的特征选择与机器学习方法研究进展
Sheng Wu Gong Cheng Xue Bao. 2019 Sep 25;35(9):1619-1632. doi: 10.13345/j.cjb.190064.
4
Proteomics-Based Machine Learning Approach as an Alternative to Conventional Biomarkers for Differential Diagnosis of Chronic Kidney Diseases.基于蛋白质组学的机器学习方法可作为传统生物标志物的替代品，用于慢性肾脏病的鉴别诊断。
Int J Mol Sci. 2020 Jul 7;21(13):4802. doi: 10.3390/ijms21134802.
5
Integrative transcriptomic, proteomic, and machine learning approach to identifying feature genes of atrial fibrillation using atrial samples from patients with valvular heart disease.综合转录组学、蛋白质组学和机器学习方法，利用瓣膜性心脏病患者的心房样本识别心房颤动的特征基因。
BMC Cardiovasc Disord. 2021 Jan 28;21(1):52. doi: 10.1186/s12872-020-01819-0.
6
Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease.血浆蛋白质组学筛选鉴定出与非酒精性脂肪性肝病患者显著/进展性纤维化相关的潜在非侵入性生物标志物。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20190395.
7
Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4/FF4 study.低肌肉量和高脂肪量的蛋白质组学特征：KORA S4/FF4 研究中的机器学习方法。
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):1011-1023. doi: 10.1002/jcsm.12733. Epub 2021 Jun 20.
8
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis.蛋白质组学方法在类风湿关节炎缓解期和复发风险中的应用。
Front Immunol. 2021 Nov 18;12:729681. doi: 10.3389/fimmu.2021.729681. eCollection 2021.
9
Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.尿蛋白质组学鉴定肝细胞癌的非侵入性诊断生物标志物。
J Proteomics. 2020 Aug 15;225:103780. doi: 10.1016/j.jprot.2020.103780. Epub 2020 Apr 13.
10
Derivative component analysis for mass spectral serum proteomic profiles.质谱血清蛋白质组图谱的衍生成分分析。
BMC Med Genomics. 2014;7 Suppl 1(Suppl 1):S5. doi: 10.1186/1755-8794-7-S1-S5. Epub 2014 May 8.

本文引用的文献

1
Noninvasive proteomic biomarkers for alcohol-related liver disease.用于酒精性肝病的非侵入性蛋白质组学生物标志物。
Nat Med. 2022 Jun;28(6):1277-1287. doi: 10.1038/s41591-022-01850-y. Epub 2022 Jun 2.
2
Therapeutic advances in alcohol-associated hepatitis.酒精相关性肝炎的治疗进展。
J Hepatol. 2022 Jun;76(6):1279-1290. doi: 10.1016/j.jhep.2022.03.025.
3
Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.酒精性肝病进展的肝脏特异性、系统性和遗传因素。
Z Gastroenterol. 2022 Jan;60(1):36-44. doi: 10.1055/a-1714-9330. Epub 2022 Jan 18.
4
Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.酒精性肝炎的蛋白质组学分析揭示糖蛋白 NMB（GPNMB）作为一种新的肝和血清生物标志物。
Alcohol. 2022 Mar;99:35-48. doi: 10.1016/j.alcohol.2021.11.005. Epub 2021 Dec 17.
5
Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.解决酒精相关性肝病临床未满足需求和挑战的研究方法。
Hepatology. 2022 Apr;75(4):1026-1037. doi: 10.1002/hep.32143. Epub 2021 Nov 27.
6
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis.整合多组学揭示葡萄糖代谢重编程，并鉴定出酒精性肝炎中的一种新型己糖激酶。
Gastroenterology. 2021 Apr;160(5):1725-1740.e2. doi: 10.1053/j.gastro.2020.12.008. Epub 2020 Dec 10.
7
Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.新兴的非侵入性生物标志物和酒精性肝炎的医学管理策略：现有认识和范围。
Cells. 2020 Feb 25;9(3):524. doi: 10.3390/cells9030524.
8
Current trials and novel therapeutic targets for alcoholic hepatitis.目前治疗酒精性肝炎的试验和新的治疗靶点。
J Hepatol. 2019 Feb;70(2):305-313. doi: 10.1016/j.jhep.2018.10.026.
9
Organ-Organ Crosstalk and Alcoholic Liver Disease.器官-器官间的相互作用与酒精性肝病
Biomolecules. 2017 Aug 16;7(3):62. doi: 10.3390/biom7030062.
10
Therapy for alcoholic liver disease.酒精性肝病的治疗
World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143.